vs
Side-by-side financial comparison of IDEX Corporation (IEX) and iRhythm Holdings, Inc. (IRTC). Click either name above to swap in a different company.
IDEX Corporation is the larger business by last-quarter revenue ($398.4M vs $208.9M, roughly 1.9× iRhythm Holdings, Inc.). IDEX Corporation runs the higher net margin — 30.1% vs 2.7%, a 27.4% gap on every dollar of revenue. On growth, iRhythm Holdings, Inc. posted the faster year-over-year revenue change (27.1% vs 16.7%). IDEX Corporation produced more free cash flow last quarter ($86.0M vs $14.5M). Over the past eight quarters, iRhythm Holdings, Inc.'s revenue compounded faster (25.8% CAGR vs -29.4%).
IDEX can refer to several things, including:International Defence Exhibition, a biennial arms and defense technology sales exhibition IDEX Corporation, a publicly listed company that makes fluidics systems and specialty engineered products Ideanomics, a publicly traded company that trades under the IDEX ticker symbol.
iRhythm Holdings is a digital healthcare company focused on cardiac care, developing and commercializing wearable ambulatory heart monitoring devices paired with AI-powered analytical tools. It primarily serves healthcare providers and patients across the United States, helping to detect undiagnosed arrhythmias such as atrial fibrillation through convenient long-term heart rhythm tracking that delivers actionable clinical insights.
IEX vs IRTC — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $398.4M | $208.9M |
| Net Profit | $120.0M | $5.6M |
| Gross Margin | 99.9% | 70.9% |
| Operating Margin | 43.3% | 1.1% |
| Net Margin | 30.1% | 2.7% |
| Revenue YoY | 16.7% | 27.1% |
| Net Profit YoY | 25.7% | 518.5% |
| EPS (diluted) | $1.61 | $0.18 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q2 26 | $398.4M | — | ||
| Q1 26 | $407.7M | — | ||
| Q4 25 | $899.1M | $208.9M | ||
| Q3 25 | $878.7M | $192.9M | ||
| Q2 25 | $865.4M | $186.7M | ||
| Q1 25 | $814.3M | $158.7M | ||
| Q4 24 | $862.9M | $164.3M | ||
| Q3 24 | $798.2M | $147.5M |
| Q2 26 | $120.0M | — | ||
| Q1 26 | $128.3M | — | ||
| Q4 25 | $128.3M | $5.6M | ||
| Q3 25 | $127.8M | $-5.2M | ||
| Q2 25 | $131.6M | $-14.2M | ||
| Q1 25 | $95.5M | $-30.7M | ||
| Q4 24 | $123.2M | $-1.3M | ||
| Q3 24 | $119.1M | $-46.2M |
| Q2 26 | 99.9% | — | ||
| Q1 26 | 94.9% | — | ||
| Q4 25 | 43.1% | 70.9% | ||
| Q3 25 | 44.5% | 71.1% | ||
| Q2 25 | 45.3% | 71.2% | ||
| Q1 25 | 45.3% | 68.8% | ||
| Q4 24 | 42.5% | 70.0% | ||
| Q3 24 | 44.3% | 68.8% |
| Q2 26 | 43.3% | — | ||
| Q1 26 | 45.0% | — | ||
| Q4 25 | 20.4% | 1.1% | ||
| Q3 25 | 21.1% | -4.4% | ||
| Q2 25 | 21.7% | -10.0% | ||
| Q1 25 | 17.4% | -20.5% | ||
| Q4 24 | 19.2% | -2.5% | ||
| Q3 24 | 21.0% | -34.1% |
| Q2 26 | 30.1% | — | ||
| Q1 26 | 31.5% | — | ||
| Q4 25 | 14.3% | 2.7% | ||
| Q3 25 | 14.5% | -2.7% | ||
| Q2 25 | 15.2% | -7.6% | ||
| Q1 25 | 11.7% | -19.3% | ||
| Q4 24 | 14.3% | -0.8% | ||
| Q3 24 | 14.9% | -31.3% |
| Q2 26 | $1.61 | — | ||
| Q1 26 | $1.71 | — | ||
| Q4 25 | $1.71 | $0.18 | ||
| Q3 25 | $1.70 | $-0.16 | ||
| Q2 25 | $1.74 | $-0.44 | ||
| Q1 25 | $1.26 | $-0.97 | ||
| Q4 24 | $1.61 | $-0.03 | ||
| Q3 24 | $1.57 | $-1.48 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $586.2M | $583.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $4.0B | $152.7M |
| Total Assets | $6.9B | $1.0B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q2 26 | $586.2M | — | ||
| Q1 26 | $580.0M | — | ||
| Q4 25 | $580.0M | $583.8M | ||
| Q3 25 | $593.8M | $565.2M | ||
| Q2 25 | $568.2M | $545.5M | ||
| Q1 25 | $594.1M | $520.6M | ||
| Q4 24 | $620.8M | $535.6M | ||
| Q3 24 | $633.2M | $522.0M |
| Q2 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | $1.8B | — | ||
| Q3 25 | $1.9B | — | ||
| Q2 25 | $1.9B | — | ||
| Q1 25 | $2.0B | — | ||
| Q4 24 | $2.0B | — | ||
| Q3 24 | $2.1B | — |
| Q2 26 | $4.0B | — | ||
| Q1 26 | $4.0B | — | ||
| Q4 25 | $4.0B | $152.7M | ||
| Q3 25 | $4.0B | $121.9M | ||
| Q2 25 | $4.0B | $103.7M | ||
| Q1 25 | $3.9B | $86.7M | ||
| Q4 24 | $3.8B | $90.9M | ||
| Q3 24 | $3.8B | $71.8M |
| Q2 26 | $6.9B | — | ||
| Q1 26 | $6.9B | — | ||
| Q4 25 | $6.9B | $1.0B | ||
| Q3 25 | $7.0B | $995.2M | ||
| Q2 25 | $6.9B | $964.0M | ||
| Q1 25 | $6.8B | $926.1M | ||
| Q4 24 | $6.7B | $931.4M | ||
| Q3 24 | $7.0B | $909.7M |
| Q2 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | 0.45× | — | ||
| Q3 25 | 0.48× | — | ||
| Q2 25 | 0.46× | — | ||
| Q1 25 | 0.50× | — | ||
| Q4 24 | 0.52× | — | ||
| Q3 24 | 0.55× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $26.2M |
| Free Cash FlowOCF − Capex | $86.0M | $14.5M |
| FCF MarginFCF / Revenue | 21.6% | 6.9% |
| Capex IntensityCapex / Revenue | 4.4% | 5.6% |
| Cash ConversionOCF / Net Profit | — | 4.70× |
| TTM Free Cash FlowTrailing 4 quarters | $654.3M | $34.5M |
8-quarter trend — quarters aligned by calendar period.
| Q2 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | $209.5M | $26.2M | ||
| Q3 25 | $203.5M | $34.9M | ||
| Q2 25 | $161.7M | $27.7M | ||
| Q1 25 | $105.7M | $-7.9M | ||
| Q4 24 | $172.6M | $19.2M | ||
| Q3 24 | $205.3M | $24.3M |
| Q2 26 | $86.0M | — | ||
| Q1 26 | $189.8M | — | ||
| Q4 25 | $189.8M | $14.5M | ||
| Q3 25 | $188.7M | $20.1M | ||
| Q2 25 | $146.9M | $17.3M | ||
| Q1 25 | $91.4M | $-17.3M | ||
| Q4 24 | $157.1M | $12.4M | ||
| Q3 24 | $191.6M | $15.5M |
| Q2 26 | 21.6% | — | ||
| Q1 26 | 46.6% | — | ||
| Q4 25 | 21.1% | 6.9% | ||
| Q3 25 | 21.5% | 10.4% | ||
| Q2 25 | 17.0% | 9.3% | ||
| Q1 25 | 11.2% | -10.9% | ||
| Q4 24 | 18.2% | 7.5% | ||
| Q3 24 | 24.0% | 10.5% |
| Q2 26 | 4.4% | — | ||
| Q1 26 | 15.6% | — | ||
| Q4 25 | 2.2% | 5.6% | ||
| Q3 25 | 1.7% | 7.7% | ||
| Q2 25 | 1.7% | 5.6% | ||
| Q1 25 | 1.8% | 5.9% | ||
| Q4 24 | 1.8% | 4.2% | ||
| Q3 24 | 1.7% | 6.0% |
| Q2 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | 1.63× | 4.70× | ||
| Q3 25 | 1.59× | — | ||
| Q2 25 | 1.23× | — | ||
| Q1 25 | 1.11× | — | ||
| Q4 24 | 1.40× | — | ||
| Q3 24 | 1.72× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
IEX
Segment breakdown not available.
IRTC
| Commercial Payors | $111.7M | 53% |
| Centers For Medicare And Medicaid | $49.2M | 24% |
| Healthcare Institutions | $34.3M | 16% |
| Non Contracted Third Party Payors | $13.7M | 7% |
